Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

APREAPRE
5 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in APREA THERAPEUTICS INC

CITADEL ADVISORS LLC holds 58,600 shares of APRE (APREA THERAPEUTICS INC), worth $47,015 as of 2026-Q2. This is a new position.

Current Value

$47,015

Current Shares

58,600

Total Value Change

-$14,354

Total Shares Change

+28,517

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
58,600
-
$47,0150.0%$0.80
31
2026-Q1
Exited
0
-100.0%
$00.0%$0.85
0
2025-Q4
New
51,041
-
$43,5380.0%$0.89
31
2025-Q2
Exited
0
-100.0%
$00.0%$1.67
0
2025-Q1
New
30,083
-
$61,3690.0%$2.09
32

Other major holders of APRE: VANGUARD GROUP INC, Walleye Capital LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used